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macrophages during endotoxin-induced uveitis
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Purpose: To investigate the dynamics and distribution of toll-like receptor 4 (TLR4)-positive cells and resident tissue
macrophages in the uvea during endotoxin-induced uveitis (EIU) in Wistar rats.
Methods: Wistar rats (n=40) received a footpad injection of 200 μg of Vibrio cholera lipopolysaccharide (LPS), and the
intensity of anterior segment inflammation was evaluated after the LPS injection. Ten rats each were killed 6, 12, 24 and
48 h after injection. Ten normal Wistar rats were killed as controls (0 h). The iris-ciliary body complex and choroids from
each eye were removed and subdivided into segments. Immunohistochemical localization of TLR4 and a resident tissue
macrophage marker, cluster of differentiation 163 (CD163), was performed on whole mount isolated iris-ciliary body
complexes and choroids. TLR4+ and CD163+ cells in the iris were manually counted, and the cell density (cells/mm2) was
calculated. The distribution patterns and phenotypes of cells expressing these two proteins were further characterized by
double-labeled immunofluorescence studies.
Results: The iris-ciliary body complex did not express TLR4 in normal rats. TLR4+ cells were detectable in the iris stroma
6 h after injection, and the number significantly increased (p<0.001 by one-way ANOVA) 12, 24, and 48 h after injection.
The morphology of TLR4+ cells hardly changed 12–48 h after injection. CD163 was expressed in the uvea in all rats.
During the inflammatory response phase (0–48 h after injection), the proportion of CD163+ tissue macrophages having a
round  morphology  increased  (p<0.001  by  one-way  ANOVA)  concurrently  with  a  decrease  in  the  proportion  of
dendritiform CD163+ cells. These changes occurred mainly in the macrophages located in the stroma bordering the iris
endothelial layer. Double-labeling immunofluorescence demonstrated the co-expression of TLR4 and CD163 in round
stroma cells with TLR4 located at the cell membrane and CD163 in the cytoplasm. TLR4+ cells could not be detected in
choroids in any of the rats.
Conclusions:  The  results  of  the  present  study  indicate  that  TLR4  expression  increased  in  the  iris  and  iris  tissue
macrophages expressed TLR4 during EIU. This has significant implications for the understanding of ocular inflammation
and for interpreting the potential role of Gram-negative bacteria in the pathogenesis of acute anterior uveitis.
Uveitis is an intraocular inflammatory disease which is
potentially  sight  threatening.  Uveitis  can  be  classified  as
anterior  uveitis,  intermediate  uveitis,  posterior  uveitis,  or
panuveitis [1]. Anterior uveitis is the most common form of
uveitis. The etiology of uveitis is unclear, but it is speculated
to be an autoimmune response resulting from a breakdown in
the normal state of ocular immune privilege [2]. Extensive
clinical  and  experimental  evidence  support  the  role  of
particular  Gram-negative  bacteria  or  their
lipopolysaccharides  (LPS)  in  the  pathogenesis  of
noninfectious,  immune-mediated  acute  anterior  uveitis
(AAU),  particularly  those  that  are  associated  with  human
leukocyte antigen-B27 (HLA-B27; see a recent review by
Chang et al. [3]). Furthermore, in endotoxin-induced uveitis
(EIU),  a  well  established  animal  model  of  AAU  [4],  an
injection  of  LPS  to  certain  susceptible  strains  of  rodents
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induces an acute and preferential inflammation of the iris and
ciliary body that closely resembles AAU in humans.
Toll-like  receptors  (TLRs)  are  a  family  of  type  I
transmembrane pattern-recognition receptors (PRRs) that are
essential in the recognition of the highly conserved pathogen-
associated molecular patterns (PAMPs) [5,6]. Stimulation of
the TLR by its specific PAMP results in the activation of an
immunostimulatory  and  immunomodulatory  cell  signaling
pathway  that  is  essential  for  innate  immunity  and  the
activation of the adaptive immune response [7,8]. It is now
well known that TLR4 is the primary signaling receptor for
LPS-specific recognition and cellular activation [9]. TLR4
expression  has  been  demonstrated  on  macrophages,
peripheral blood monocytes, dendritic cells (DCs), and dermal
vascular  endothelial  cells  as  well  as  in  various  tissues
[10-13]. One of the earliest phagocytes to respond to infection
is the tissue macrophage, which originates as monocytes in
the  peripheral  blood  system  [14].  Activation  of  TLR4+
macrophages  by  LPS  induces  various  proinflammatory
cytokines,  chemokines,  and  antimicrobial  activities.
Therefore, these innate immune cells are expected to be able
to  respond  rapidly  to  LPS  of  Gram-negative  bacteria.
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619Macrophages  play  a  key  role  in  the  pathogenesis  of  EIU
[15].
Cluster  of  differentiation  163  (CD163)  is  a  group  B
cysteine-rich scavenger receptor that is exclusively expressed
by  cells  of  the  monocyte–macrophage  lineage  [16]  and
functions  as  a  scavenger  receptor  for  hemoglobin–
haptoglobin complexes [17]. The activation of human CD163
results  in  the  production  of  pro-  and  anti-inflammatory
cytokines,  suggesting  a  potential  role  of  CD163  in  host
defense and/or inflammation [18,19]. Rat CD163 is a marker
for  most  mature  tissue  macrophages  and  can  trigger  the
production of pro-inflammatory mediators in macrophages
[20]. McMenamin and Crewe [21] have previously reported
the kinetics of tissue macrophages in the iris during EIU and
demonstrated  that  the  number  of  cells  with  round-
pleiomorphic  morphology  increased  0–24  h  after  LPS
injection.
Chang and colleagues [2,22] have reported the expression
of  TLR4  and  its  associated  lipopolysaccharide  receptor
complex in resident antigen-presenting cells in the human
uvea in vivo. Human ciliary body non-pigmented epithelial
cells also showed TLR4 expression [23]. Recently, de Kozak
et al. [24] detected the expression of TLR4 in the epithelium
of the Lewis rat iris and in several ectodermal dysplasia 1
(ED1)-positive cells adjacent to this epithelial layer during
EIU.
The  uveal  tract  has  a  particular  predilection  for
involvement in intraocular inflammation, and Gram-negative
bacteria may also play a role in the pathogenesis of AAU. The
purpose of the present study was to investigate the dynamics
and  distribution  of  TLR4+  cells  and  resident  tissue
macrophages in the iris during the progression of EIU in
Wistar rats.
METHODS
Animals: Adult male pathogen-free Wistar rats (8–10 weeks
old, weighing 150–200 g) were obtained from the Capital
Medical University Animal Resource Centre (Beijing, China)
and housed in 12 h light/12 h dark cycles. Throughout this
study, all procedures adhered to the Institute for Laboratory
Animal Research guidelines (Guide for the Care and Use of
Laboratory Animals). Fifty animals were used in the study.
Animals were randomly divided into five groups (n=10 per
group) for the following time points: before LPS injection (0
h; control group) and 6, 12, 24, and 48 h after LPS injection.
Immunization  and  tissue  preparation:  Endotoxin-induced
uveitis  was  induced  as  previously  described  [21].
Lipopolysaccharide (V. cholera, classical Biotype, serotype
Ogawa) was kindly provided by Lanzhou Institute of Biologic
Products (Lanzhou, China). Each animal (except the control
group)  received  a  single  injection  in  one  rear  footpad  of
200 μg LPS dissolved in 250 μl sterile saline (NS). The eyes
were examined by slit microscope before the injection and at
2 h intervals after the injection, and the intensity of anterior
segment  inflammation  was  evaluated.  As  previously
described [19], the severity of uveitis was graded from 0 to 4
by  a  masked  investigator  as  follows:  0=no  inflammation;
1=discrete  vasodilatation  of  the  iris  and  the  conjunctiva
vessels; 2=moderate dilatation of the iris and the conjunctival
vessels with moderate flare in the anterior chamber; 3=intense
iridal hyperemia with intense flare in the anterior chamber;
and 4=the same clinical signs as 3 with fibrinous exudates in
the pupillary area. Animals were killed either before LPS
injection (0 h; control group) or 6, 12, 24, or 48 h after the
injection.  Rats  were  perfused,  and  whole  mounts  of  the
choroids and iris-ciliary body complexes were prepared as
described below.
Single-labeling immunohistochemistry of uvea whole mounts:
Immunohistochemistry of uvea whole mounts was performed
according to previously reported methods [25,26]. After the
eyes were observed using a slit microscope, the rats were
killed  by  an  overdose  of  pentobarbital  (100  mg/kg
bodyweight; Sigma, St. Louis, MO) and flushed through the
left ventricle of the heart with 250–350 ml of cold (4 °C)
phosphate-buffered saline (PBS), 1 IU heparin per ml of PBS,
and 250 ml of cold (4 °C) 4% paraformaldehyde. Eyes were
enucleated and fixed in 4% paraformaldehyde for 1–2 h. The
iris–ciliary body complex and choroid were gently dissected
from the eyes and stored in PBS at –80 °C. The tissues were
defrosted for 3 min at 37 °C before use.
Polyclonal antibody TLR4 was purchased from Santa
Cruz  (sc-30002,  rabbit  polyclonal  antibody;  Santa  Cruz
Biotechnology,  Santa  Cruz,CA).  Monoclonal  antibody
CD163 (MCA342GA) and mouse IgG1 (MCA1209) were
purchased from Serotec (Oxford, UK), and affinity purified
normal  rabbit  IgG  was  purchased  from  Boster  (Boster
Biotechnology, Wuhan, China). Other reagents used were
PV-6000 (polymer detection system for immuno-histological
staining;  Zhongshan  Goldbridge  Biotechnology,  Beijing,
China)  and  a  3,  3′-diaminobenzidine  tetrahydrochloride
substrate kit (DAB; Zhongshan Goldbridge Biotechnology,
Beijing, China).
Endogenous peroxidase activity in the whole mounts was
blocked by 0.3% H2O2 for 30 min at room temperature. After
three washes with PBS (10 min each), tissue pieces were
incubated in small, sealed glass vials containing pre-warmed
20 mM EDTA tetrasodium for 30 min at 37 °C. Whole mounts
were then placed in individual wells in a flat-bottomed 24 well
plate and quickly rinsed with PBS three times at 10 min per
rinse. Increased permeability of the tissue was achieved by
replacing PBS with a 0.1% solution of Tween-20 in PBS plus
0.5% Triton X-100. The whole mounts were incubated with
3% bovine serum albumin (BSA)/PBS for 30 min at room
temperature to block non-specific binding. Tissues were then
incubated with the primary antibodies appropriately diluted in
3%  BSA/PBS  overnight  at  4  °C.  The  following  primary
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620monoclonal antibodies against the indicated specificity in rat
tissues  were  used:  anti-TLR4  (2  μg/ml)  and  anti-CD163
(2 μg/ml). After three washes with PBS, the tissues were
incubated with PV-6000 secondary antibodies for 30 min at
room temperature. After three further washes in PBS, the
tissues were incubated with DAB. The reaction was stopped
once suitable color had developed or after a maximum of 10
min. The whole mounts were placed in clean glass vials and
dehydrated through an ascending alcohol and xylene gradient
and  then  placed  in  a  drop  of  mounting  medium  (Balsam
neutral)  and  xylene  on  a  microscope  slide.  As  a  positive
control, rat spleen cryostat sections were stained for TLR4.
Negative controls were performed by replacing the primary
antibody  with  species-matched  and  isotype-matched
antibodies at the same concentrations of the primary antibody.
Double-labeled  immunofluorescence:  Double-labeled
immunofluorescence was performed by serially incubating
the tissues with two primary antibodies of different species.
After blocking non-specific binding with 10% normal goat
serum,  the  tissues  were  incubated  with  the  first  primary
antibody, rabbit anti-rat TLR4 polyclonal antibody (4 μg/ml)
Figure 1. Clinical manifestation of EIU in Wistar rats. A: The image
shows  the  eye  24  h  after  the  LPS  injection.  Note  the  fibrinous
pupillary membrane (arrow). B: The image shows the eye 48 h after
the  LPS  injection.  The  fibrinous  pupillary  membrane  has  been
absorbed (arrow).
overnight at 4 °C. After they were washed with PBS, tissues
were incubated with fluorescein-conjugated AffiniPure goat
anti-rabbit IgG (Zhongshan Goldbridge Biotechnology) for 2
h in the dark at room temperature. All subsequent steps were
performed with the tissues protected from light. The tissues
were washed with PBS and then incubated with the second
primary antibody, anti-CD163 (2 μg/ml) overnight at 4 °C.
After they were washed with PBS, tissues were incubated with
rhodamine-conjugated  AffiniPure  goat  anti-mouse  IgG
(Zhongshan  Goldbridge  Biotechnology)  for  2  h  at  room
temperature. After three washes with PBS for 10 min each,
slides  were  mounted  in  80%  glycerin.  Negative  controls
included replacing the first or second primary antibody or both
antibodies  with  species-  and  isotype-matched  irrelevant
antibodies.
Slides were examined under a fluorescence microscope
(Leica-DM-4000B; Leica, Wetzlar, Germany). Images were
captured,  and  the  pairs  of  images  were  superimposed  for
colocalization  analysis  using  image-management  software
(Adobe  Photoshop  CS3.  10.0;  Adobe  Systems,  Mountain
View, CA). Double immunofluorescence of whole mounts
was  also  examined  by  inverted  confocal  laser  scanning
microscope (Leica-DM-IRE2; Leica).
Quantitative analysis: The distribution of immunopositive
cells within the rat iris whole mounts was used for quantitative
analysis.  Positively  stained  cells  were  classified  during
counting as either dendritiform (possessing one, two, or more
long, thin, cytoplasmic dendritic processes) or non-dendritic,
which was either pleiomorphic (irregular with short, broad
cytoplasmic extensions) or round-ovoid [27]. Different layers
Figure 2. Clinical evaluation and TLR4+ and CD163+ cells in the iris
during  the  course  of  EIU.  A:  The  clinical  score  of  EIU  and
inflammation reached their maximum at 24 h. B: The density of
TLR4+ cells in the rat iris had increased greatly 12 h after injection.
C: There are no obvious changes in the density of CD163+ cells in
the rat iris within 24 h, but the density had increased 48 h after
injection. D: Percentage of round-pleiomorphic CD163+ cells in the
rat iris during the course of EIU is shown in the chart. Significant
differences compared with the controls at a level of p<0.001 are
shown by asterisks.
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621of stained cells could be distinguished in separate focal planes
of the whole mounts. All the cells of different layers in one
field  were  counted  as  the  total  number  of  this  field.
Immunostained cells were counted in the field located in the
middle of the iris whole mount. Four separate fields under a
microscope with 40X objective lens were counted by a single
masked observer, and the mean number of cells/mm2 of each
rat was calculated. For CD163+ cells, the percent of round-
pleiomorphic cells of all positive cells was calculated. All the
eyes in each group were examined, and mean numbers were
calculated for the group. Positive cell density and the percent
of round-pleiomorphic CD163+cells were analyzed by one-
way  ANOVA  followed  by  Least  Significant  Difference
Procedure (LSD) tests for multiple comparisons, using SPSS
11.0 (SPSS Inc., Chicago, IL). A p value less than or equal to
0.05 was considered significant. Data are expressed as means
±standard deviation (SD). Single asterisks in figures indicates
p≤0.001.
RESULTS
Clinical  manifestation  of  endotoxin-induced  uveitis:  Eyes
were examined under a slit microscope, and the intensity of
the  anterior  segment  inflammation  was  evaluated.  Blood
vessels in the iris began to dilate within 4 h after the LPS
injection. Examination of the anterior chamber with a slit lamp
did not reveal flare or exudation for up to 8 h. At 12–16 h, a
fibrinous  pupillary  membrane  could  be  seen,  reaching  a
maximum  at  18–24  h.  Hypopyon  was  also  occasionally
observed. Generally, inflammation subsided gradually after
24 h, and the exudation had decreased 48 h after LPS injection
(Figure 1A,B; Figure 2A).
Density, distribution, and morphology of TLR4+ cells in the
iris,  ciliary  body,  and  choroid:  Lipopolysaccharides  can
upregulate  the  expression  of  TLR4.  TLR4  could  not  be
detected in the iris–ciliary body complex in the control group
(0 h). At 6 h, a small number of TLR4+ cells were detected in
the irises of two rats. The weakly positive cells exhibited
pleiomorphic  morphology  and  were  located  near  blood
vessels (Figure 3B). The number of TLR4+ cells increased
significantly (p<0.001) in the iris and ciliary body of all rats
at 12 h with a density of 506±39 cells/mm2 (Figure 2B), and
the immunopositive cells were predominantly round-ovoid
cells  (Figure  3F)  whose  morphology  was  hardly  altered
between 12 and 48 h after the LPS injection (Figure 3C,D).
The TLR4+ cells were mainly distributed in the stroma of the
iris  and  in  the  perivascular  location.  TLR4  could  not  be
detected in the choroid of any Wistar rats.
Density, distribution, and morphology of CD163+ cells in the
iris, ciliary body, and choroid: The rat CD163 antigen has
been identified as an ectodermal dysplasia 2 (ED2) antigen
[20], and monoclonal antibody ED2 is a well recognized anti-
rat tissue macrophage marker. The network of CD163+ tissue
macrophages  in  the  current  study  was  predominantly  of
dendritiform  appearance  during  the  first  6  h  after  LPS
injection  (Figure  4A,B).  At  12  h,  the  morphology  of  the
positive cells in the iris was markedly changed. The cells
possessed fewer dendritic processes, and the proportion of
round-ovoid  cells  was  increased  (Figure  4C–E).  The
percentage  of  cells  with  round-pleiomorphic  appearance
increased from 13% in the control rats before injection to
approximately  80%  of  the  cell  population  12–48  h  after
injection (p<0.001; Figure 2D). The changes occurred mainly
in  the  macrophages  located  in  the  stroma  near  the  iris
endothelial  layer  (Figure  5A–F).  During  the  EIU
inflammatory  process,  there  was  little  change  in  the  total
density of CD163+ cells (Figure 2C). However, 48 h after
injection,  small,  round,  distinctive  positive  cells  were
observed (Figure 4E).
In  addition,  we  detected  tissue  macrophages  in  the
peripheral  choroid,  which  adjoins  the  ciliary  body.  The
CD163+ cells were large and dendritiform in appearance, and
the  overall  density  and  morphology  remained  unchanged
during EIU (Figure 4F,G).
Co-expression of TLR4 and CD163 in the iris: To determine
the  phenotype  of  TLR4+  cells  in  the  iris,  a  double-
immunofluorescence study was performed. Iris whole mounts
were  double-labeled  for  TLR4  with  a  green-emitting
fluorochrome (FITC; Figure 3F) and for CD163 with a red-
emitting  fluorochrome  (TRITC,  Figure  3G).  Some  round
stromal cells were confirmed to co-express TLR4 and CD163.
Confocal microscopy confirmed that TLR4 was located in the
cellular membrane while CD163 was located in the cytoplasm
(Figure  3H).  There  were  also  subpopulations  of  TLR4+/
CD163-cells  and  TLR4-/CD163+  tissue  macrophages.  No
dendritiform CD163+ cell coexpressed TLR4.
DISCUSSION
The  results  presented  here  have  demonstrated  that  the
expression  of  TLR4  in  the  iris  is  upregulated  during
endotoxin-induced uveitis. Furthermore, we have shown that
some of the TLR4+ cells are resident tissue macrophages.
These  findings  have  significant  implications  for  our
understanding of the innate and adaptive immunity of the eye
as well as for the pathogenesis of AAU.
It  is  becoming  increasingly  apparent  that  particular
Gram-negative bacteria or their lipopolysaccharides may be
important  in  the  pathogenesis  of  noninfectious  immune-
mediated HLA-B27-associated AAU [3]. A recent study with
patients with AAU also supports this hypothesis [2]. Chang et
al.  [2]  reported  that  TLR4  stimulation  of  whole  blood  in
patients with active AAU resulted in a significantly reduced
production of pro-inflammatory cytokines such as interleukin
6 (IL-6) and interferon α (IFN-α). This phenomenon was
consistent  with  the  observation  of  a  functional  state  of
endotoxin tolerance. Pre-exposure to LPS reduces sensitivity
to a subsequent challenge with LPS. This transient functional
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622Figure 3. Immunohistochemical studies
for  TLR4  in  iris  whole  mounts  at
different times after LPS injection. The
dynamics  of  TLR4+  cells  in  the  iris
during  EIU  are  shown  (A–D).  A:
Positive cells could not be detected in
the control rats. Arrows represent blood
vessels. B: The TLR4+ cells possessed
pleiomorphic morphology at 6 h. Note
the positive cells (arrowhead) that are
located  adjacent  to  blood  vessels
(arrow).  C:  Most  of  the  TLR4+  cells
possessed round-ovoid morphology at
24 h (arrowhead). Note the positive cells
that are located adjacent to blood vessels
(arrow). D: The TLR4+ cells at 48 h are
shown.  The  morphology  and
distribution of the positive cells were
similar to that at 24 h. E: No staining was
seen  in  the  iris  when  under  identical
experimental conditions when replacing
of  the  primary  antibody  with  normal
rabbit  IgG  at  the  same  concentration
(negative control). The arrows indicate
blood  vessels.  F–H:  Double
immunofluorescence  by  confocal
microscopy  revealed  co-expression
(arrow)  of  TLR4  (green)  and  CD163
(red) by resident stromal cells in the iris.
I: Positive tissue control shows positive
staining for TLR4 by a subpopulation of
macrophage-like cells in the normal rat
spleen. J: A higher power view is shown
where  the  arrow  and  arrowheads
represent the same cells as in panel I.
K: No staining was seen in the spleen
when  using  identical  experimental
conditions but with the replacement of
the primary antibody with normal rabbit
IgG at the same concentration (negative
control).  Original  magnification:  B–
D,F–H,J 400X; A,E,I,K 200X.
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623state  of  LPS  hypo-responsiveness  is  known  as  endotoxin
tolerance. These findings suggest that patients with active
AAU had been recently exposed to LPS.
Endotoxin-induced uveitis is a well established animal
model of AAU. Injection of LPS from Gram-negative bacteria
at  sites  remote  from  the  eye  induces  AAU  without
significantly affecting other tissues [4,28]. In this study, we
detected the upregulated expression of TLR4 in the iris after
LPS injection and TLR4 expression preceding the maximal
clinical inflammation. The distribution of TLR4, which was
predominantly in the iris and the ciliary body, was consistent
with anterior segment inflammation in AAU. These results
suggest a role for TLR4 in the pathogenesis of AAU. We also
show that some TLR4+ cells are resident tissue macrophages.
Figure 4. Immunohistochemical studies
for CD163 in the iris and choroid whole
mounts  at  different  times  after  LPS
injection. A–E: CD163+ resident tissue
macrophages in the control rats (A) and
at 6 h (B), 12 h (C), 24 h(D), and 48h
(E) after LPS injection in the iris. Note
the  increase  in  the  number  of  round-
pleiomorphic cells between 12 and 48 h
and  the  numerous  small  round  cells
(arrow)  at  48  h  (E).  The  large
dendritiform  CD163+  cells  were
unchanged  in  the  peripheral  choroid
between 0 h (F) and 12 h (G). Original
magnification: A–E 200X; F,G 400X.
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624Tissue macrophages are one of the earliest phagocytes to
respond to infection [14,20]. In the present study, the finding
that the TLR4+ tissue macrophages are located in the stroma
and perivascular locations within the iris suggests that such
cells are optimally positioned to assess and to respond to LPS
of invasive organisms that have breached the blood–ocular
barrier. Activation of TLR4 on macrophages by LPS results
in the activation of the transcriptional factor, nuclear factor-
κB  (NF-κB),  via  an  immunostimulatory  intracellular
signaling pathway. Consequently, the induction of various
proinflammatory cytokines, chemokines, and antimicrobial
activities  [29]  initiates  a  rapid  inflammatory  response
characterized by the recruitment of leukocytes to the site of
infection to eliminate the invading pathogen.
TLR4 expressed on professional antigen presenting cells
(APCs)  such  as  macrophages  and  DCs  are  a  critical  link
between the innate and adaptive immunity. Chang et al. [22]
reported a network of TLR4+ APCs, mostly HLA-DR+ DCs,
in the normal human iris root and the ciliary body. De Kozak
and colleagues [24] discovered TLR4 expression in ED1-
positive cells (macrophages and dendritic cells) in the iris
stroma of EIU. TLR-mediated activation of DCs induces DC
maturation  with  the  production  of  pro-inflammatory
cytokines  and  upregulation  of  costimulatory  and  major
histocompatibility complex (MHC) molecules to enhance the
antigen  presenting  capacity  of  DCs  [30,31].  Thus,  TLR
stimulation of APCs leads to the activation and priming of
antigen-specific, naive T cells, triggering the adaptive arm of
the immune response. Activation of TLR4 in DCs induces
production  of  IL-12,  thereby  skewing  the  differentiation
toward the T helper cell 1(Th1) type [6,30,31]. Thus, TLRs
are important in both triggering and modulating the activation
of the adaptive immune response [30,32]. There are various
potential mechanisms of Gram-negative bacteria and TLR4
involvement in the pathogenesis of AAU. First, LPS-mediated
activation of TLR4 may be one of the earliest initiating factors
Figure  5.  CD163+  cells  displayed
different  morphologies  at  different
layers in the iris 48 h after LPS injection.
This  figure  shows  different  stromal
layers from the epithelial to endothelial
(from  A  to  F)  in  the  same  field.
Dendritiform  cells  are  located  in  the
stroma adjacent to the epithelial layer
(A) while round-pleiomorphic cells are
adjacent to the endothelial layer (F). The
cells that arrows and arrowheads point
to represent the same cells, respectively.
Original magnification: A–F 400X.
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625in  the  development  of  AAU  [2].  Inappropriate  TLR4-
mediated  activation  of  the  innate  and  adaptive  immune
responses within the uvea by LPS may be a major contributing
factor in the initiating mechanisms of AAU. TLR4-mediated
activation of resident uveal APCs may initiate the breakdown
of the ocular immune privilege, resulting in the induction of
an  autoimmune  response  [22].  Second,  products  of  tissue
inflammation as endogenous ligands for TLR4 may contribute
to the perpetuation of uveitis. Intriguingly, such endogenous
ligands, including fibronectin, heat shock proteins (HSPs),
hyaluronic acid, and host-derived RNA, are released upon
tissue damage and cell stress, events that are likely to occur
during inflammatory conditions [33]. The activation of cells
by endogenous components from distressed or injured cells
supports  the  so-called  “Danger  Model”  proposed  by
Matzinger [34]. This theory suggests that the immune system
is more concerned with damage than with foreignness and is
activated by alarm signals from injured tissues rather than by
the recognition of non-self. This may be a mechanism for the
perpetuation  of  uveitis  and  the  progression  to  chronic
inflammation because the products of tissue inflammation
further stimulate the immune cells that have infiltrated the eye
via TLR4. In addition, the heightened ability to respond to
LPS in inactive anterior uveitis patients may predispose these
individuals to the development of ocular inflammation by
LPS-mediated  TLR4  activation.  Endotoxin  tolerance  is  a
transient state [2]. Huhtinen et al. reported that patients with
a history of AAU but not with active uveitis have higher
functional responsiveness to LPS. The heightened ability to
respond  to  LPS  was  significant  in  the  presence  of  a  low
concentration of LPS (10 ng/ml). At such low concentrations,
monocyte  activation  is  mediated  specifically  via  a  high-
affinity  LPS  receptor  complex,  TLR4,  myeloid
differentiation-2  (MD-2),  and  cluster  of  differentiation  14
(CD14). Huhtinen et al. [35] also reported that patients with
previous  anterior  uveitis  had  smoldering  systemic
inflammation,  which  was  promoted  by  innate  immunity
mechanisms and not by chronic T cell activation.
Here, we report that the normal Wistar rat iris does not
express TLR4 whereas Chang et al. [22] had detected TLR4+
APCs in the normal human uvea. We found that the TLR4+
cells in the Wistar rats were predominantly round-ovoid cells,
which was different from the dendritiform positive cells in the
normal human iris. This may be due to species differences.
The TLR4+ cells in two rats 6 h after injection were weakly
positive and pleiomorphic, and it is also possible that TLR4
is expressed in the normal rat uvea at low or undetectable
constitutive  levels.  Upregulation  of  TLR4  from  their
undetectable constitutive levels in normal rats may occur in
response to LPS injection. The pleiomorphic cells in rats 6 h
after  injection  had  a  range  of  dendritiform  and  round
appearance,  implying  that  the  morphologic  changes  of
TLR4+ cells occur during EIU. More study on rats between 6
and 12 h after LPS injection are required to confirm this
finding. De Kozak [24] previously reported the expression of
TLR4  in  the  iris  epithelium  of  Lewis  rats  using  cryostat
sections. We did not detect TLR4 in the iris epithelium of
Wistar rats using iris whole mounts. The different findings
may be due to differences between Lewis and Wistar rats or
because of the different staining methods used. We used iris
whole mount immunohistochemical methods in the present
study. The advantages of this approach are the more rapid
tissue preparation time, visualization of the morphology of
entire cells and cell networks, and the increased sampling of
tissue.  However,  the  observation  of  the  iris  epithelium
cytomembrane in whole mounts is less clear than in sections.
Macrophages have various functions and play a critical
role  in  host  defense.  However,  macrophages  are
heterogeneous and exhibit a wide range of phenotypes with
regard to their morphology, cell surface antigen expression,
and function [36]. Rat CD163 (rat ED2 antigen) is a marker
for most mature tissue macrophages but is not expressed in rat
monocytes [20]. McMenamin [21] previously reported the
kinetics of ED2+ tissue macrophages in the iris during EIU
and  demonstrated  that  the  number  of  cells  with  round-
pleiomorphic appearance increased over a period of 24 h after
injection,  which  was  concurrent  with  the  decrease  in  the
proportion of dendritiform ED2+ cells. We extended these
findings and confirmed in the current study that the cells with
shape alterations were only located in the stroma bordering
the iris endothelial layer. The layer of tissue macrophages
bordering the iris epithelium was not affected by LPS. Yang
et al. [37,38] have previously reported that LPS injection
induces early adherence of monocytes to rat retinal blood
vessels,  which  was  followed  by  a  massive  influx  of
macrophages into the retina. They also detected that ED2+
cells showed a variety of morphologic appearances after LPS
injection, including large round cells, pleiomorphic cells, and
dendritiform  cells.  Therefore,  these  round-pleiomorphic
positive cells in the present study were probably recently
matured tissue macrophages, which originated from blood
monocytes. Whether these different morphologic cells have
different roles in the onset and development of EIU is not yet
known. A large number of round TLR4– tissue macrophages
were  observed  in  this  study.  Whether  the  TLR4–  tissue
macrophages  and  the  TLR4+  tissue  macrophages  have
different functions was not investigated in the present study.
Further studies to examine the phenotype and function of the
macrophages  are  therefore  necessary.  The  present  study
showed a higher proportion of the round-pleiomorphic cells
after LPS injection than in a previous report [21]. This may
be due to the higher dose of LPS injection (200 μg of LPS per
rat) than that used in the previous study (100 μg of LPS per
rat).
In summary, the results of the present study revealed the
expression of TLR4 and CD163 in the uvea during EIU. The
preferential expression of TLR4 on tissue macrophages within
the iris and ciliary body suggests a novel mechanism for the
Molecular Vision 2009; 15:619-628 <http://www.molvis.org/molvis/v15/a63> © 2009 Molecular Vision
626initiating  factors  and  immunopathogenesis  of  uveitis,
particularly  HLA-B27-associated  AAU.  Further  studies,
including functional studies, are required to identify the roles
of these receptors in the context of uveitis.
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